Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jul 2, 2025 · Filed Jul 2, 2025
The CEO of Exozymes paid $11K out of pocket for Exozymes shares. It was the first purchase in 6 months. Shares held went up 11% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$10,629
Shares × reported transaction price
<$25K
+10.8%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 6 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 3 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.1% | +0.1% | +1.0% |
| 30 days | +0.3% | +0.9% | −0.6% |
| 90 days | +41.3% | +6.9% | +34.4% |
| 180 days | +12.3% | +9.9% | +2.4% |
| 365 days | −17.9% | +20.1% | −38.0% |
Past results only. Not a forecast.